Recently, Sinopharm Foreign Trade signed a contract with Moregate Biotech, New Zealand, to become the national importer and authorized distributor of its fetal bovine serum products.

Both Sinopharm Foreign Trade and Moregate Biotech will jointly promote the in-depth development of Moregate Biotech fetal bovine serum products in the Chinese market, which also marks the second expansion of Sinopharm Foreign Trade in life sciences products.

About Moregate Biotech

Founded in 1975, Moregate Biotech continues to be one of the few major Australian/New Zealand serum producers utilizing state of the art facilities, designed specifically to meet cGMP standards and IS9001 certification across its operation. It is also one of the few manufacturers licensed to transfuse blood products to China. Moregate Biotech has won a reputation over many decades for its absolute commitment to product quality, reliability and customer service.